Catalyst Wire Dossier Catalyst Wire Dossier

AcSDKP-NH2

N-acetyl-Ser-Asp-Lys-Pro-amide · Assistance Publique - Hôpitaux de Paris
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AcSDKP-NH2, covering 2017-03-01 to 2017-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2) [Phase 1, Phase 2]

See pricing